Search results
Results from the WOW.Com Content Network
Metadoxine is a selective antagonist of the serotonin receptor subtype 5-HT 2B and displays high affinity to the gamma-aminobutyric acid (GABA) transporter. In vitro enzymatic assay revealed that metadoxine reduced the activity of the GABA transaminase enzyme, responsible for the degradation of GABA.
While the medication metadoxine may speed the breakdown of alcohol, use in alcohol intoxication requires further study as of 2017. [6] [30] It is approved in a number of countries in Europe, as well as India and Brazil. [30] Additional medication may be indicated for treatment of nausea, tremor, and anxiety.
Metadoxine [sustained/extended-release] (pyridoxine-pyrrolidone carboxylate, pyridoxine pidolate; MDX, metadoxine SR, MG-01CI) – serotonin 5-HT 2B receptor antagonist, GABA modulator, other actions [84] Methylphenidate [transdermal patch] (TAH-9901) – norepinephrine–dopamine reuptake inhibitor [85]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
ATC code A05 Bile and liver therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
6-MeO-DMT, or 6-methoxy-N,N-dimethyltryptamine, also known as 6-OMe-DMT, is a serotonergic drug of the tryptamine family. [1] [2] It is the 6-methoxy derivative of the serotonergic psychedelic N,N-dimethyltryptamine (DMT) and is a positional isomer of the serotonergic psychedelic 5-MeO-DMT.
3357 15559 Ensembl ENSG00000135914 ENSMUSG00000026228 UniProt P41595 Q02152 RefSeq (mRNA) NM_000867 NM_001320758 NM_008311 RefSeq (protein) NP_000858 NP_001307687 NP_032337 Location (UCSC) Chr 2: 231.11 – 231.13 Mb Chr 1: 86.03 – 86.04 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse 5-Hydroxytryptamine receptor 2B (5-HT 2B) also known as serotonin receptor 2B is a protein that in ...
RH-34 is a compound which acts as a potent and selective partial agonist for the 5-HT 2A serotonin receptor subtype. It was derived by structural modification of the selective 5-HT 2A antagonist ketanserin, with the 4-(p-fluorobenzoyl)piperidine moiety replaced by the N-(2-methoxybenzyl) pharmacophore found in such potent 5-HT 2A agonists as NBOMe-2C-B and NBOMe-2C-I.